General
HKBU develops world-first dual imaging and inhibiting agent in suppressing EBV-associated tumours
 

HKBU develops world-first dual imaging and inhibiting agent in suppressing EBV-associated tumours

Shared by:

 
Scholars at Hong Kong Baptist University (HKBU) along with their collaborators recently announced the world’s first chemical compound (probe) that can simultaneously detect and inhibit Epstein-Barr virus (EBV)-infected tumour cells in mice, with an efficacy rate of above 90%.
 
today.mims.com
 
19 Sep 2017 - General